JSR Life Sciences LLC (“JSR Life Sciences”), a global leader in life sciences materials and services, announces it has entered into a definitive agreement to transfer Crown Bioscience Inc. (“Crown Bioscience”) to Adicon Holdings Limited (“Adicon”), a premier independent clinical laboratory provider in China and a portfolio company of The Carlyle Group. Crown Bioscience’s comprehensive portfolio of translational oncology services, including its world-leading patient-derived xenograft (PDX) models, tumor organoid platforms, immuno-oncology assays, and bioinformatics solutions, will transition to Adicon, positioning the company to accelerate advancements in precision medicine and drug discovery for oncology.
Read the full article: JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited //
Source: https://www.businesswire.com/news/home/20251113226279/en/JSR-Life-Sciences-Enters-Definitive-Agreement-to-Transfer-Crown-Bioscience-to-Adicon-Holdings-Limited